Hau, Sofie Olsson http://orcid.org/0000-0002-1702-9884
Svensson, Maja
Petersson, Alexandra
Eberhard, Jakob
Jirström, Karin
Funding for this research was provided by:
Vetenskapsrådet (2015-03598, 2018-02441)
Cancerfonden (CAN2018/418, 21 1596 Pj)
Sjöbergstiftelsen
Lennart Glans Stiftelse
Fru Berta Kamprads Stiftelse
BioCARE
Ingrid och Sverker Perssons Stiftelse
Medicinska Fakulteten, Lunds Universitet
Governmental Funding of Clinical Research
Skånes universitetssjukhus
Lund University
Article History
Received: 17 July 2023
Accepted: 24 October 2023
First Online: 7 November 2023
Declarations
:
: Patients are given study information by their oncologist and research nurse and, if they choose to participate, give their informed, written consent. The treatment regimen follows Swedish national guidelines and is not affected by the study.The study has been approved by the Regional Ethical Review Board (nr: LU 2018/13) and the Swedish Ethical Review Authority (amendments 2021–00166 and 2021–06065). The study protocol complies with the Helsinki declaration.
: Not applicable.
: The authors declare no competing interests.